In today’s environment it becomes of increasing importance to intensify partnerships in order to be able to innovate, deliver the highest quality, and secure future growth at competitive conditions. All these elements are intrinsically part of the partnership between Lonza and DSM Nutritional Products.
„We are very pleased to continue our partnership with DSM. The common utilization of the infrastructure is benefiting both partners. The extended partnership is also a promising commitment to the production sites of Visp and Lalden, showing that they are able to deliver high quality products at competitive costs”, comments Lonza CEO Stefan Borgas. „We have many interests in common here in Visp and Lalden and the collaboration between Lonza and DSM is very close. We are excited about the extension of the existing partnership by many years”, adds Leendert Staal, President and CEO of DSM Nutritional Products.
The collaboration between the companies dates back to 1965, when the predecessor company Teranol AG was founded to produce vitamin A and E. As Lonza commissioned at that same time its cracker, which could supply the necessary raw materials acetylene and hydrogen, the decision was made to locate the new Teranol production site in Lalden next to existing Lonza infrastructure.
About Lonza
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Lonza is also a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets. Lonza is headquartered in Basel, Switzerland and is listed on
Forward-looking statements
This press release contains forward-looking statements. These statements are based on current expectations, estimates and projections of DSM, and information currently available to the company. The statements involve certain risks and uncertainties that are difficult to predict and therefore DSM does not guarantee that its expectations will be realized. Furthermore, DSM has no obligation to update the statements contained in this press release. The English-language version of the press release is leading.
the SIX Swiss Exchange. In 2008, Lonza had sales of CHF 2.937 billion. Further information can be found at www.lonza.com.
About DSM Nutritional Products
DSM Nutritional Products is the world's leading supplier of vitamins, carotenoids and other fine chemicals to the feed, food, pharmaceutical and personal care industries. The business has sales of over EUR 2 billion and a long tradition as a pioneer in the discovery of new products, new formulations and attractive applications for all industry segments. More information at www.dsmnutritionalproducts.com
About DSM – the Life Sciences and Materials Sciences Company
Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to quality of life. DSM’s products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM has annual net sales of EUR 9.3 billion and employs some 23,500 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com
